Maria Souli1,2,3, Felicia Ruffin1, Seong-Ho Choi1,4, Lawrence P Park1,5, Shengli Gao1,6, Nicholas Christopoulos Lent1, Batu K Sharma-Kuinkel1, Joshua T Thaden1, Stacey A Maskarinec1, Lisa Wanda1,7, Jonathan Hill-Rorie1,8, Bobby Warren1, Brenda Hansen1,9, Vance G Fowler1,2. 1. Department of Medicine, Duke University Medical Center, North Carolina. 2. Duke Clinical Research Institute, Durham, North Carolina. 3. Fourth Department of Internal Medicine, National and Kapodistrian University of Athens School of Medicine, Greece. 4. Department of Internal Medicine, Division of Infectious Diseases, Chung-Ang University College of Medicine, Seoul, South Korea. 5. Duke Global Health Institute, Duke University, Durham, North Carolina. 6. The First People's Hospital of Wujiang District, Suzhou City, Jiangsu Province, China. 7. School of Medicine, University of North Carolina, Chapel Hill. 8. Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 9. Pediatric Gastroenterology, University of North Carolina, Chapel Hill.
Abstract
BACKGROUND: We conducted a longitudinal study to evaluate changes in the clinical presentation and epidemiology of Staphylococcus aureus bacteremia (SAB) in an academic, US medical center. METHODS: Consecutive patients with monomicrobial SAB were enrolled from January 1995 to December 2015. Each person's initial bloodstream S. aureus isolate was genotyped using spa typing. Clonal complexes (CCs) were assigned using Ridom StaphType software. Changes over time in both the patient and bacterial characteristics were estimated with linear regression. Associations between genotypes or clinical characteristics and complications were estimated using multivariable regression models. RESULTS: Among the 2348 eligible participants, 54.2% had an implantable, foreign body of some type. This proportion increased significantly during the 21-year study period, by 0.96% annually (P = .002), as did comorbid conditions and acquisition outside of the hospital. Rates of any metastatic complication also significantly increased, by 0.94% annually (P = .019). Among the corresponding bloodstream S. aureus isolates, spa-CC012 (multi-locus sequence type [MLST] CC30), -CC004 (MLST CC45), -CC189 (MLST CC1), and -CC084 (MLST CC15) all significantly declined during the study period, while spa-CC008 (MLST CC8) significantly increased. Patients with SAB due to spa-CC008 were significantly more likely to develop metastatic complications in general, and abscesses, septic emboli, and persistent bacteremia in particular. After adjusting for demographic, racial, and clinical variables, the USA300 variant of spa-CC008 was independently associated with metastatic complications (odds ratio 1.42; 95% confidence interval 1.02-1.99). CONCLUSIONS: Systematic approaches for monitoring complications of SAB and genotyping the corresponding bloodstream isolates will help identify the emergence of hypervirulent clones and likely improve clinical management of this syndrome.
BACKGROUND: We conducted a longitudinal study to evaluate changes in the clinical presentation and epidemiology of Staphylococcus aureus bacteremia (SAB) in an academic, US medical center. METHODS: Consecutive patients with monomicrobial SAB were enrolled from January 1995 to December 2015. Each person's initial bloodstream S. aureus isolate was genotyped using spa typing. Clonal complexes (CCs) were assigned using Ridom StaphType software. Changes over time in both the patient and bacterial characteristics were estimated with linear regression. Associations between genotypes or clinical characteristics and complications were estimated using multivariable regression models. RESULTS: Among the 2348 eligible participants, 54.2% had an implantable, foreign body of some type. This proportion increased significantly during the 21-year study period, by 0.96% annually (P = .002), as did comorbid conditions and acquisition outside of the hospital. Rates of any metastatic complication also significantly increased, by 0.94% annually (P = .019). Among the corresponding bloodstream S. aureus isolates, spa-CC012 (multi-locus sequence type [MLST] CC30), -CC004 (MLST CC45), -CC189 (MLST CC1), and -CC084 (MLST CC15) all significantly declined during the study period, while spa-CC008 (MLST CC8) significantly increased. Patients with SAB due to spa-CC008 were significantly more likely to develop metastatic complications in general, and abscesses, septic emboli, and persistent bacteremia in particular. After adjusting for demographic, racial, and clinical variables, the USA300 variant of spa-CC008 was independently associated with metastatic complications (odds ratio 1.42; 95% confidence interval 1.02-1.99). CONCLUSIONS: Systematic approaches for monitoring complications of SAB and genotyping the corresponding bloodstream isolates will help identify the emergence of hypervirulent clones and likely improve clinical management of this syndrome.
Authors: Vance G Fowler; Charlotte L Nelson; Lauren M McIntyre; Barry N Kreiswirth; Alastair Monk; Gordon L Archer; Jerome Federspiel; Steven Naidich; Brian Remortel; Thomas Rude; Pamela Brown; L Barth Reller; G Ralph Corey; Steven R Gill Journal: J Infect Dis Date: 2007-07-20 Impact factor: 5.226
Authors: Isabella A Tickler; Richard V Goering; Jose R Mediavilla; Barry N Kreiswirth; Fred C Tenover Journal: Diagn Microbiol Infect Dis Date: 2017-05-06 Impact factor: 2.803
Authors: N Deborah Friedman; Keith S Kaye; Jason E Stout; Sarah A McGarry; Sharon L Trivette; Jane P Briggs; Wanda Lamm; Connie Clark; Jennifer MacFarquhar; Aaron L Walton; L Barth Reller; Daniel J Sexton Journal: Ann Intern Med Date: 2002-11-19 Impact factor: 25.391
Authors: Juhsien J C Nienaber; Batu K Sharma Kuinkel; Michael Clarke-Pearson; Supaporn Lamlertthon; Lawrence Park; Thomas H Rude; Steve Barriere; Christopher W Woods; Vivian H Chu; Mercedes Marín; Suzana Bukovski; Patricia Garcia; G Ralph Corey; Tony Korman; Thanh Doco-Lecompte; David R Murdoch; L Barth Reller; Vance G Fowler Journal: J Infect Dis Date: 2011-09-01 Impact factor: 5.226
Authors: Jeffrey Sherwood; Matthew Park; Paul Robben; Timothy Whitman; Michael W Ellis Journal: Infect Control Hosp Epidemiol Date: 2013-02-15 Impact factor: 3.254
Authors: Binh An Diep; Amy M Palazzolo-Ballance; Pierre Tattevin; Li Basuino; Kevin R Braughton; Adeline R Whitney; Liang Chen; Barry N Kreiswirth; Michael Otto; Frank R DeLeo; Henry F Chambers Journal: PLoS One Date: 2008-09-12 Impact factor: 3.240
Authors: F Patrick O'Hara; Jose A Suaya; G Thomas Ray; Roger Baxter; Megan L Brown; Robertino M Mera; Nicole M Close; Elizabeth Thomas; Heather Amrine-Madsen Journal: Microb Drug Resist Date: 2015-12-15 Impact factor: 3.431
Authors: Vance G Fowler; Anita F Das; Joy Lipka-Diamond; Raymond Schuch; Roger Pomerantz; Luis Jáuregui-Peredo; Adam Bressler; David Evans; Gregory J Moran; Mark E Rupp; Robert Wise; G Ralph Corey; Marcus Zervos; Pamela S Douglas; Cara Cassino Journal: J Clin Invest Date: 2020-07-01 Impact factor: 14.808
Authors: Emily M Eichenberger; Christiaan R de Vries; Felicia Ruffin; Batu Sharma-Kuinkel; Lawrence Park; David Hong; Erick R Scott; Lily Blair; Nicholas Degner; Desiree H Hollemon; Timothy A Blauwkamp; Carine Ho; Hon Seng; Pratik Shah; Lisa Wanda; Vance G Fowler; Asim A Ahmed Journal: Clin Infect Dis Date: 2022-06-10 Impact factor: 20.999
Authors: Emily M Eichenberger; Felicia Ruffin; Batu Sharma-Kuinkel; Michael Dagher; Lawrence Park; Celia Kohler; Matthew R Sinclair; Stacey A Maskarinec; Vance G Fowler Journal: Transpl Infect Dis Date: 2021-12-16 Impact factor: 2.228
Authors: Matthew R Sinclair; Maria Souli; Felicia Ruffin; Lawrence P Park; Michael Dagher; Emily M Eichenberger; Stacey A Maskarinec; Joshua T Thaden; Michael Mohnasky; Christina M Wyatt; Vance G Fowler Journal: Am J Kidney Dis Date: 2021-07-23 Impact factor: 8.860